Pentwater Capital Management LP Verona Pharma PLC Transaction History
Pentwater Capital Management LP
- $15.9 Billion
- Q3 2025
A detailed history of Pentwater Capital Management LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Pentwater Capital Management LP holds 5,300,000 shares of VRNA stock, worth $567 Million. This represents 3.55% of its overall portfolio holdings.
Number of Shares
5,300,000Holding current value
$567 Million% of portfolio
3.55%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
72.8MCall Options Held
652KPut Options Held
637K-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
-
Glazer Capital, LLC New York, NY3.21MShares$343 Million11.48% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...